Focused On-demand Library for Cathepsin S

Focused On-demand Libraries - Reaxense Collaboration

Explore the Potential with AI-Driven Innovation

The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.

Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.

In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.

Our top-notch dedicated system is used to design specialised libraries for enzymes.

Fig. 1. The sreening workflow of Receptor.AI

The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.

Key features that set our library apart include:

The Receptor.AI platform integrates extensive information about the target protein, such as historical experiments, academic research, known ligands, and structural insights, thereby increasing the likelihood of identifying highly relevant compounds.
The platform’s sophisticated molecular simulations are designed to discover potential binding sites, ensuring that our focused library is optimal for the discovery of allosteric inhibitors and binders for cryptic pockets.
With over 50 customisable AI models, verified through extensive testing in commercial drug discovery and research, Receptor.AI is efficient, reliable, and precise. These models are essential in the production of our focused libraries.
Receptor.AI not only produces focused libraries but also provides full services and solutions at every stage of preclinical drug discovery, with a success-based pricing structure that aligns our interests with the success of your project.

partner

Reaxense

upacc

P25774

UPID:

CATS_HUMAN

Alternative names:

Alternative UPACC:

P25774; B4DWC9; D3DV05; Q5T5I0; Q6FHS5; Q9BUG3

Background:

Cathepsin S, encoded by the gene with accession number P25774, is a thiol protease pivotal in the immune response. It plays a crucial role in the processing of the invariant chain from MHC class II molecules, facilitating MHC class II antigen presentation. This process is essential for the adaptive immune system to recognize and respond to foreign antigens.

Therapeutic significance:

Understanding the role of Cathepsin S could open doors to potential therapeutic strategies. Its critical function in antigen presentation suggests that modulation of Cathepsin S activity could influence immune responses, making it a target of interest in autoimmune diseases and cancer immunotherapy.